Elk-1 inhibitors target the Elk-1 transcription factor. Elk-1 belongs to the ETS (E twenty-six) family of transcription factors, which are crucial regulators of gene expression. Transcription factors like Elk-1 play a pivotal role in orchestrating cellular responses to various external stimuli, including growth factors, hormones, and environmental cues. When activated, Elk-1 translocates to the cell nucleus and binds to specific DNA sequences known as ETS-binding sites in the promoters of target genes. This binding event, in turn, regulates the transcription of these genes, leading to the production of proteins that control fundamental cellular processes. These processes encompass cell growth, proliferation, differentiation, survival, and responses to stress. Elk-1 inhibitors are meticulously designed to interfere with the ability of Elk-1 to bind to its target DNA sequences. By doing so, these inhibitors disrupt the transcriptional regulation of genes that would otherwise be activated by Elk-1 in response to specific external signals. The downstream effects of Elk-1 inhibition are diverse and depend on the particular set of target genes in a given cellular context.
The development of Elk-1 inhibitors has provided valuable insights into the complex regulatory networks that govern cellular behavior. Researchers utilize these inhibitors to study the specific roles of Elk-1 in various cellular processes, dissecting the intricate signaling pathways that underlie these events. Through their use, scientists have uncovered new facets of cellular biology related to Elk-1-mediated signaling.The chemical structures of Elk-1 inhibitors can vary significantly, and their precise modes of action might differ based on their molecular properties. Researchers continually refine and optimize these compounds to enhance their potency and selectivity for Elk-1, minimizing any off-target effects that could interfere with other cellular processes. It is essential to emphasize that while Elk-1 inhibitors show immense promise as powerful research tools, their use remains primarily focused on elucidating the fundamental mechanisms of cellular regulation. Elk-1 inhibitors interfere with Elk-1's ability to bind to specific DNA sequences, modulating gene expression and cellular responses to external stimuli.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $209.00 $872.00 | 12 | |
EHT 1864 inhibits the Rac family of small GTPases, which are upstream regulators of Elk-1. By blocking Rac activation, it interferes with the downstream ERK pathway and inhibits Elk-1 activation and subsequent gene transcription. | ||||||
CGP 57380 | 522629-08-9 | sc-202993 | 5 mg | $172.00 | 6 | |
CGP 57380 is a specific inhibitor of the ERK1/2 MAP kinases, a pathway that activates Elk-1. By blocking ERK1/2, CGP 57380 hinders Elk-1's phosphorylation and transcriptional activity, thus reducing the expression of target genes. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y27632 is a potent inhibitor of Rho-associated protein kinase (ROCK), which regulates Elk-1 activity. By inhibiting ROCK, Y27632 indirectly suppresses Elk-1 and its transcriptional effects on target genes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a potent inhibitor of c-Jun N-terminal kinases (JNK), a pathway that interacts with Elk-1. By blocking JNK, SP600125 can modulate Elk-1 activity and gene transcription. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 is a selective inhibitor of the bromodomain and extraterminal (BET) proteins. It indirectly affects Elk-1 by inhibiting the recruitment of BET proteins to enhancer regions of Elk-1 target genes, thus downregulating their expression. | ||||||
Pelitinib | 257933-82-7 | sc-208155 | 5 mg | $430.00 | ||
Pelitinib is a specific inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase, a pathway upstream of Elk-1 activation. By blocking EGFR, EKB-569 can suppress Elk-1 and its downstream transcriptional activity. | ||||||
ERK Inhibitor II, FR180204 | 865362-74-9 | sc-203945 sc-203945A sc-203945B sc-203945C | 1 mg 5 mg 10 mg 50 mg | $108.00 $162.00 $234.00 $924.00 | 45 | |
FR180204 is a selective inhibitor of ERK1/2 kinases. By targeting ERK1/2, it reduces Elk-1 activation and its subsequent transcriptional effects on target genes. | ||||||
Halofuginone | 55837-20-2 | sc-507290 | 100 mg | $1740.00 | ||
Halofuginone inhibits the phosphorylation of eIF2α, a downstream target of Elk-1. By blocking this pathway, it indirectly affects Elk-1 activity and gene expression. | ||||||